Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Sinovac Biotech Ltd (SVA)

Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, `SARS`, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019
Sales 448,270 1,492,760 19,374,900 510,620 246,050
Sales Growth -69.97% -92.30% +3,694.39% +107.53% +7.14%
Net Income -99,920 113,870 8,467,480 110,370 44,930
Net Income Growth -187.75% -98.66% +7,571.90% +145.65% +106.29%

Balance Sheet

(Values in U.S. Thousands) Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019
Total Assets 13,657,970 14,114,570 16,748,170 1,901,330 452,300
Total Assets Growth -3.24% -15.72% +780.87% +320.37% +22.32%
Total Liabilities 1,635,210 1,401,910 2,872,170 781,200 100,100
Total Liabilities Growth +16.64% -51.19% +267.66% +680.42% +28.58%

Cash Flow

(Values in U.S. Thousands) Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019
Operating Cash Flow 104,000 -770,750 15,352,540 479,310 39,070
Operating Cash Flow Growth +113.49% -105.02% +3,103.05% +1,126.80% +392.07%
Net Cash Flow -3,011,080 -7,333,380 10,569,560 894,330 -2,290
Change in Net Cash Flow +58.94% -169.38% +1,081.84% +39,153.73% -105.43%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot